The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Precision Toxicology and Efficacy News, IVO, Insightful Insights The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Ovarian cancer is the most lethal gynecological cancer in the [...] Jack Crawford2022-02-16T09:52:11+00:00Tags: Cancer Xenografts, preclinical, oncology models, Hera Biolabs, Cancer, rat model, drug discovery, OncoRat, Oncology, Xenografts, Cell Line Xenografts, Humanized Rats, in vivo model, drug resistance, Immunodeficient Rats, OV81, OV81.2, ovarian cancer, gynecological Cancer, Analise DiFeo, Chemo-induced stemness, NSG Mice, The Cancer Genome Atlas, TCGA| Read More